Executive Team
Biopharmaceutical leadership and scientific expertise guiding the Apitox development program.
Dr. Christopher Kim, MD
Inventor & Developer of Apitox | Pain Medicine Specialist
Program Leadership & Scientific Governance
As Chief Scientific Officer, Dr. Kim will lead the scientific, clinical, and regulatory development of the Company’s APITOX program, including research and development, clinical strategy, regulatory engagement, and activities directed toward obtaining regulatory approvals and advancing the program toward commercialization.
Dr. Kim has been closely associated with the APITOX program for many years and possesses extensive scientific, technical, and regulatory expertise relating to its research, development, and clinical advancement. His appointment provides continuity in the program’s leadership and strengthens the Company’s ability to execute its long-term development strategy as it advances APITOX through the regulatory process and toward commercialization.
Professional Background & Clinical Leadership
Dr. Christopher Kim is the inventor and developer of Apitox and has played a central role in its clinical development in Korea and the United States. His professional background spans pain medicine, clinical research and academic medicine. He served as President of the International Pain Institute of New Jersey from 1983 to 2003 and as a professor at the Biomedical Center of CHA Graduate School of Medicine in Korea from 2005 to 2017.
Dr. Kim is a licensed physician in New Jersey, New York and Korea and is an American Board-certified pain medicine specialist. He received his medical degree from the School of Medicine at CN University in Korea.
Career & Innovation Highlights
Decades of leadership spanning academic medicine, clinical pain management, and biopharmaceutical innovation.
Apitox Invention
Inventor and developer of Apitox, spearheading clinical development pathways in Korea and the United States.
Pain Medicine Leadership
Served as President of the International Pain Institute of New Jersey for 20 years (1983–2003).
Academic Professorship
Professor at the Biomedical Center of CHA Graduate School of Medicine in Korea from 2005 to 2017.
Board Certified Specialist
American Board-certified pain medicine specialist with medical licensure across New Jersey, New York, and Korea.
Important Corporate Clarification
Nexus Biosys is presented within the Apimeds Pharmaceuticals US corporate platform as a biopharmaceutical business focused on the Apitox development program. Nexus Biosys is not separately listed on a stock exchange. References to NYSE American and the symbol APUS relate exclusively to Apimeds Pharmaceuticals US, Inc.